Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Researchers at Roche synthesize new mGlu5 receptor modulators

May 16, 2014

Heron Therapeutics selects HTX-011 as lead candidate for post-surgical pain program

May 16, 2014

Clinical trial tests the efficacy, safety and tolerability of selisistat

May 16, 2014

Eisai resubmits additional benefit dossier for Fycompa in Germany

May 15, 2014

Daewoong Pharmaceutical synthesizes novel Na(V)1.7 blockers

May 15, 2014

Revive Therapeutics reports preclinical data for REV-003

May 15, 2014

Early clinical and preclinical data presented for DS-5565

May 15, 2014

Lysosomal Therapeutics receives funding for neurodegenerative disease research

May 14, 2014

Inovio acquires rights to preclinical therapies for Alzheimer's and MS

May 14, 2014

FDA clears transfer of orphan drug designation for intrathecal resiniferatoxin to Sorrento

May 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...